Specifically, they demonstrated that overexpression of Thymocyte Expressed Molecule Involved In Selection 2 (THEMIS2) in breast cancer promotes the binding of Protein-Tyrosine Phosphatases 1B (PTP1B) to MET, leading to MET activation, and ultimately sustaining stemness characteristics. Here, MET is linked to breast carcinoma.